Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de C. David Nicholson, PhD
Age : 62
Public asset : 2,678,298 USD
Linked companies : Allergan plc - Actinium Pharmaceuticals Inc
Summary 
Dr. C. D. Nicholson is Chief Research & Development Officer at Allergan Plc.

He is on the Board of Directors at Transcelerate Biopharma, Inc. and Actinium Pharmaceuticals, Inc. Dr. Nicholson was previously employed as Head-Research & Development by Bayer CropScience AG, Senior Vice President & Head-Worldwide Licensing by Merck & Co., Inc., and Executive Vice President-Research & Development by Organon Biosciences, Inc.

He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.

He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Wales.


Current positions of C. David Nicholson, PhD 
NameTitle Since
Allergan plc
(Pharmaceuticals)
Chief Research & Development Officer 2014
Actinium Pharmaceuticals Inc
(Biotechnology & Medical Research)
Independent Director 2008
Transcelerate Biopharma, Inc. Vice Chairman 2017


Holdings of C. David Nicholson, PhD 
NameEquities%Valuation
Allergan plc (AGN)
Pharmaceuticals
13,0400.0039%2,672,548 USD
Actinium Pharmaceuticals Inc (ATNM)
Biotechnology & Medical Research
10,0000.012%5,750 USD


C. David Nicholson, PhD: Personal Network 


Most Read News 
10/12 RICHARD BRANSON : Richard Branson takes another bet on the future with Hyperloop One
10/17DJSUMNER REDSTONE : Redstone's Ex-Companion Sues His Daughter, Grandson
10/11 NELSON PELTZ : Peltz's Procter & Gamble defeat could be more humbling than harmful
10/12 JAMIE DIMON : JPMorgan CFO dials back Dimon's bitcoin criticism
10/11 JEAN COUTU : Canada's Metro to sell majority stake in Couche Tard for C$1.5 billion
10/17 FRANCK RIBOUD : Riboud to stand down as Danone chairman - Le Monde
10/13 DAVID HENRY : JPMorgan's card gamble lures millennial travelers, squeezes competitors
10/12 JACK MA : Evergrande property magnate seizes top spot on China rich list
10/12 DAVID HENRY : Loan growth helps JPMorgan beat expectations despite trading decline
10/16DJJACK MA : China's Xi Approaches a New Term With a Souring Taste for Markets
More news


© 2017 People and Ownership :   
Advertisement
C. David Nicholson, PhD : Connections 
Carnegie Mellon University
The New York Society of Security Analysts, Inc.
Vlaams Instituut Voor Biotechnologie - Flanders Institute
Remedy Pharmaceuticals, Inc.
Jamess Capital Group LLC
Soudal NV
reMYND NV
CFA Institute



Popular Business Leaders 
William Ackman Jean-paul Agon Liliane Bettencourt Jeff Bezos Vincent Bolloré John Bryant Warren Buffett Gary Cohn Tim Cook Jean Coutu Jamie Dimon Ralph Dommermuth John Edwards Emmanuel Faber Carlos Ghosn Mario Greco Stuart Gulliver David Henry Carl Icahn Joseph Jimenez Dara Khosrowshahi Karl-ludwig Kley Daniel Loeb Jack Ma Sergio Marchionne Lachlan Murdoch Elon Musk Ian Narev Peter Nicholas Michael O'leary John Paulson Nelson Peltz Wolfgang Porsche Sumner Redstone Wilbur Ross Sheryl Sandberg Charles Schwab Vishal Sikka Carlos Slim Ulrich Spiesshofer Rupert Stadler Johannes Teyssen François Villeroy De Galhau John Watson Meg Whitman Guy Wyser-pratte Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders